logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Essa H Hu

This inventor holds 15 USPTO granted patents and 1 EPO patent. Top assignees: Amgen Inc., Merck Sharp + Dohme Corp., Merck + Co., Inc.. Active years: 2010-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Essa H Hu. Retrieved from https://idiyas.com/inventor/essa-h-hu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15

% Patents Active = 26.7


Average Co-Inventor Count = 5.5

ph-index = 6

Forward Citations = 167(Granted Patents)


Location History:

  • San Diego, CA (US) (2010)
  • Camarillo, CA (US) (2010 - 2015)

Company Filing History:

goldMedal9 out of 2,069 
 
Amgen Inc.
 patents
silverMedal4 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
bronzeMedal1 out of 4,770 
 
Merck + Co., Inc.
 patents
4. 1 out of 834,453 
Other
 patents

Years Active: 2010-2015

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 8957073 - Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitors (2015-02-17),
2. 8952037 - Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors (2015-02-10),
3. 8329700 - Pyrazine compounds as phosphodiesterase 10 inhibitors (2012-12-11),
4. 8247418 - Pyrazine compounds as phosphodiesterase 10 inhibitors (2012-08-21),
5. 8163742 - Di-amino-substituted heterocyclic compounds and methods of use (2012-04-24),
6. 8063055 - Substituted pyridone compounds and methods of use (2011-11-22),
7. 8053438 - Pyrazine compounds as phosphodiesterase 10 inhibitors (2011-11-08),
8. 8008317 - Inhibitors of akt activtiy (2011-08-30),
9. 7910561 - Inhibitors of Akt activity (2011-03-22),
10. 7872128 - Benzisoxazole and isoxazolo-pyridine compounds and method of use (2011-01-18),
11. 7754717 - Bis-aryl amide compounds and methods of use (2010-07-13),
12. 7750151 - Inhibitors of Akt activity (2010-07-06),
13. 7705014 - Inhibitors of AKT activity (2010-04-27),
14. 7700607 - Substituted pyridone compounds and methods of use (2010-04-20),
15. 7700591 - Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors (2010-04-20),

Title: Innovator Spotlight: Essa H Hu - Transforming Healthcare Through Inventive Patent Solutions

Introduction: Essa H Hu, a prolific inventor based in San Diego, CA, has reshaped the landscape of pharmaceuticals with his groundbreaking patents and innovative contributions. With a stellar track record of 15 patents to his name, Essa is a driving force behind cutting-edge solutions in the field of drug development and treatment.

Latest Patents: Among Essa H Hu's latest patents are "Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitors" and "Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors." These patents focus on novel compounds that inhibit PDE10, offering promising avenues for the treatment of various disorders such as obesity, Huntington's Disease, diabetes, schizophrenia, bipolar disorder, and more.

Career Highlights: Essa H Hu's remarkable career is distinguished by his tenure at Merck Sharp & Dohme Corporation, a renowned pharmaceutical company known for its groundbreaking research and development in healthcare. As a key figure at Merck Sharp & Dohme Corporation, Essa has spearheaded numerous initiatives that have led to significant advancements in drug discovery and therapy.

Collaborations: Essa H Hu has collaborated with esteemed professionals in the industry, including Roxanne Kay Kunz and Ning Chen. These collaborations have resulted in synergistic efforts to address complex healthcare challenges and drive forward the frontiers of pharmaceutical innovation.

Conclusion: Essa H Hu stands as a beacon of ingenuity in the realm of pharmaceutical inventions, consistently pushing the boundaries of what is possible in healthcare. His groundbreaking patents and collaborative spirit underscore his unwavering commitment to driving positive change and improving the lives of individuals worldwide through transformative healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…